Literature DB >> 31808899

Primary immunodeficiencies: novel genes and unusual presentations.

Luigi D Notarangelo1, Gulbu Uzel1, V Koneti Rao1.   

Abstract

Recent advances in genomics have greatly expanded the spectrum of primary immune deficiencies (PIDs). Along with the identification of pathogenic variants in novel genes, distinct phenotypes have been associated with different variants in the same gene. Although PIDs have been historically defined based on increased susceptibility to infections, immune dysregulation has emerged as a frequent and in some cases, predominant phenotype. Autoimmune cytopenias with onset in childhood, lasting longer than 12 months, and affecting multiple lineages should raise the suspicion of a possible PID with monogenic origin. Characterization of the various molecular and cellular mechanisms responsible for these unusual manifestations of PIDs, although at times resource intensive, may allow for targeted intervention in many of them.
© 2019 by The American Society of Hematology. All rights reserved.

Entities:  

Year:  2019        PMID: 31808899      PMCID: PMC6913429          DOI: 10.1182/hematology.2019000051

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  37 in total

1.  Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.

Authors:  Joao B Oliveira; Jack J Bleesing; Umberto Dianzani; Thomas A Fleisher; Elaine S Jaffe; Michael J Lenardo; Frederic Rieux-Laucat; Richard M Siegel; Helen C Su; David T Teachey; V Koneti Rao
Journal:  Blood       Date:  2010-06-10       Impact factor: 22.113

2.  Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes.

Authors:  Jérôme Hadjadj; Nathalie Aladjidi; Helder Fernandes; Guy Leverger; Aude Magérus-Chatinet; Fabienne Mazerolles; Marie-Claude Stolzenberg; Sidonie Jacques; Capucine Picard; Jérémie Rosain; Cécile Fourrage; Sylvain Hanein; Mohammed Zarhrate; Marlène Pasquet; Wadih Abou Chahla; Vincent Barlogis; Yves Bertrand; Isabelle Pellier; Elodie Colomb Bottollier; Fanny Fouyssac; Pascale Blouin; Caroline Thomas; Nathalie Cheikh; Eric Dore; Corinne Pondarre; Dominique Plantaz; Eric Jeziorski; Frédéric Millot; Nicolas Garcelon; Stéphane Ducassou; Yves Perel; Thierry Leblanc; Bénédicte Neven; Alain Fischer; Frédéric Rieux-Laucat
Journal:  Blood       Date:  2019-04-02       Impact factor: 22.113

3.  CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes.

Authors:  Amy A Caudy; Sreelatha T Reddy; Talal Chatila; John P Atkinson; James W Verbsky
Journal:  J Allergy Clin Immunol       Date:  2006-12-27       Impact factor: 10.793

Review 4.  Tregopathies: Monogenic diseases resulting in regulatory T-cell deficiency.

Authors:  Alma-Martina Cepika; Yohei Sato; Jeffrey Mao-Hwa Liu; Molly Javier Uyeda; Rosa Bacchetta; Maria Grazia Roncarolo
Journal:  J Allergy Clin Immunol       Date:  2018-12       Impact factor: 10.793

5.  AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy.

Authors:  Bernice Lo; Kejian Zhang; Wei Lu; Lixin Zheng; Qian Zhang; Chrysi Kanellopoulou; Yu Zhang; Zhiduo Liu; Jill M Fritz; Rebecca Marsh; Ammar Husami; Diane Kissell; Shannon Nortman; Vijaya Chaturvedi; Hilary Haines; Lisa R Young; Jun Mo; Alexandra H Filipovich; Jack J Bleesing; Peter Mustillo; Michael Stephens; Cesar M Rueda; Claire A Chougnet; Kasper Hoebe; Joshua McElwee; Jason D Hughes; Elif Karakoc-Aydiner; Helen F Matthews; Susan Price; Helen C Su; V Koneti Rao; Michael J Lenardo; Michael B Jordan
Journal:  Science       Date:  2015-07-24       Impact factor: 47.728

Review 6.  Aplastic Anemia.

Authors:  Neal S Young
Journal:  N Engl J Med       Date:  2018-10-25       Impact factor: 91.245

7.  NRAS mutation causes a human autoimmune lymphoproliferative syndrome.

Authors:  João B Oliveira; Nicolas Bidère; Julie E Niemela; Lixin Zheng; Keiko Sakai; Cynthia P Nix; Robert L Danner; Jennifer Barb; Peter J Munson; Jennifer M Puck; Janet Dale; Stephen E Straus; Thomas A Fleisher; Michael J Lenardo
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-16       Impact factor: 11.205

8.  Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype.

Authors:  Julie Toubiana; Satoshi Okada; Julia Hiller; Matias Oleastro; Macarena Lagos Gomez; Juan Carlos Aldave Becerra; Marie Ouachée-Chardin; Fanny Fouyssac; Katta Mohan Girisha; Amos Etzioni; Joris Van Montfrans; Yildiz Camcioglu; Leigh Ann Kerns; Bernd Belohradsky; Stéphane Blanche; Aziz Bousfiha; Carlos Rodriguez-Gallego; Isabelle Meyts; Kai Kisand; Janine Reichenbach; Ellen D Renner; Sergio Rosenzweig; Bodo Grimbacher; Frank L van de Veerdonk; Claudia Traidl-Hoffmann; Capucine Picard; Laszlo Marodi; Tomohiro Morio; Masao Kobayashi; Desa Lilic; Joshua D Milner; Steven Holland; Jean-Laurent Casanova; Anne Puel
Journal:  Blood       Date:  2016-04-25       Impact factor: 22.113

9.  Clinical, Immunological, and Molecular Heterogeneity of 173 Patients With the Phenotype of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) Syndrome.

Authors:  Eleonora Gambineri; Sara Ciullini Mannurita; David Hagin; Marina Vignoli; Stephanie Anover-Sombke; Stacey DeBoer; Gesmar R S Segundo; Eric J Allenspach; Claudio Favre; Hans D Ochs; Troy R Torgerson
Journal:  Front Immunol       Date:  2018-11-01       Impact factor: 7.561

10.  Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease.

Authors:  Sarah E Flanagan; Emma Haapaniemi; Mark A Russell; Richard Caswell; Hana Lango Allen; Elisa De Franco; Timothy J McDonald; Hanna Rajala; Anita Ramelius; John Barton; Kaarina Heiskanen; Tarja Heiskanen-Kosma; Merja Kajosaari; Nuala P Murphy; Tatjana Milenkovic; Mikko Seppänen; Åke Lernmark; Satu Mustjoki; Timo Otonkoski; Juha Kere; Noel G Morgan; Sian Ellard; Andrew T Hattersley
Journal:  Nat Genet       Date:  2014-07-20       Impact factor: 38.330

View more
  7 in total

1.  Primary Immunodeficiency in Children With Autoimmune Cytopenias: Retrospective 154-Patient Cohort.

Authors:  Emma Westermann-Clark; Cristina Adelia Meehan; Anna K Meyer; Joseph F Dasso; Devendra Amre; Maryssa Ellison; Bhumika Patel; Marisol Betensky; Charles Isaac Hauk; Jennifer Mayer; Jonathan Metts; Jennifer W Leiding; Panida Sriaroon; Ambuj Kumar; Irmel Ayala; Jolan E Walter
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

2.  Evans syndrome: pathology and genomic hubris.

Authors:  V Koneti Rao
Journal:  Blood       Date:  2022-01-20       Impact factor: 22.113

Review 3.  Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACR.

Authors:  Nicholas L Bayless; Jeffrey A Bluestone; Samantha Bucktrout; Lisa H Butterfield; Elizabeth M Jaffee; Christian A Koch; Bart O Roep; Arlene H Sharpe; William J Murphy; Alexandra-Chloé Villani; Theresa L Walunas
Journal:  J Immunother Cancer       Date:  2021-09       Impact factor: 12.469

4.  Case report: Effectiveness of sirolimus in a de novo FAS mutation leading to autoimmune lymphoproliferative syndrome-FAS and elevated DNT/Treg ratio.

Authors:  Hao Gu; Zhenping Chen; Jie Ma; Jingyao Ma; Lingling Fu; Rui Zhang; Tianyou Wang; Runhui Wu
Journal:  Front Pediatr       Date:  2022-07-28       Impact factor: 3.569

5.  Update in Primary Immunodeficiencies.

Authors:  Lucia Leonardi; Beatrice Rivalta; Caterina Cancrini; Elena Chiappini; Claudio Cravidi; Carlo Caffarelli; Sara Manti; Mauro Calvani; Alberto Martelli; Michele Miraglia Del Giudice; Marzia Duse; Gian Luigi Marseglia; Fabio Cardinale
Journal:  Acta Biomed       Date:  2020-09-15

6.  T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome.

Authors:  Deepak Kumar; Chengyu Prince; Carolyn M Bennett; Michael Briones; Laura Lucas; Athena Russell; Kiran Patel; Satheesh Chonat; Sara Graciaa; Holly Edington; Michael H White; Lisa Kobrynski; Manar Abdalgani; Suhag Parikh; Sharat Chandra; Jack Bleesing; Rebecca Marsh; Sunita Park; Edmund K Waller; Sampath Prahalad; Shanmuganathan Chandrakasan
Journal:  Blood       Date:  2022-01-20       Impact factor: 22.113

Review 7.  Gene Editing for the Treatment of Primary Immunodeficiency Diseases.

Authors:  Rajeev Rai; Adrian J Thrasher; Alessia Cavazza
Journal:  Hum Gene Ther       Date:  2020-10-16       Impact factor: 4.793

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.